Even though traders did profit traking ,Meriil & Salaomon Smith Barney gave expectations of up to $ 55/share minimum. Now that the weak hands have been shaken out,stock would check out 41 again & then climb gradually towards $48-50 before year end. Even though FDA says efficacy not proved in pain but allowed in rheumatoid arthritis etc. Doctors when they get the drug on hand will make better judgement! Long term holders will sure see $ 55 before March. Got in @ 41,sold DEC 45 covered call twice & bought back cheaper!(small trading option profit!) Now bought DEC45 option!!
two places as a high today. Also, it is rising in afterhours trading. Also I wish we could come here without adversarial comments back and forth. I come here to help and be helped, not to argue. That's what family is for.